Cargando…

A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan

BACKGROUND: Diabetes is increasingly becoming a major health problem in Jordan and glycemic goals are often not achieved. OBJECTIVE: To explore the patients’ perspectives regarding type 2 diabetes and its management in order to “fine-tune” future pharmaceutical care intervention programs. METHOD: Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarab, Anan S., Mukattash, Tareq L., Al-Azayzih, Ahmad, Khdour, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856954/
https://www.ncbi.nlm.nih.gov/pubmed/29556120
http://dx.doi.org/10.1016/j.jsps.2018.01.013
_version_ 1783307378479857664
author Jarab, Anan S.
Mukattash, Tareq L.
Al-Azayzih, Ahmad
Khdour, Maher
author_facet Jarab, Anan S.
Mukattash, Tareq L.
Al-Azayzih, Ahmad
Khdour, Maher
author_sort Jarab, Anan S.
collection PubMed
description BACKGROUND: Diabetes is increasingly becoming a major health problem in Jordan and glycemic goals are often not achieved. OBJECTIVE: To explore the patients’ perspectives regarding type 2 diabetes and its management in order to “fine-tune” future pharmaceutical care intervention programs. METHOD: Focus groups method was used to explore views from individuals with type 2 diabetes attending outpatient diabetes clinic at the Royal Medical Services Hospital. All interviews were recorded, transcribed and analyzed using a thematic analysis approach. RESULTS: A total of 6 focus groups, with 6 participants in each one, were conducted. Participants in the present study demonstrated a great information needs about diabetes and the prescribed treatment. Medication regimen characteristics including rout of administration, number of prescribed medications and dosage frequency in addition to perceived side effects represented the major barriers to medication adherence. In addition to demonstrating negative beliefs about the illness and the prescribed medications, participants showed negative attitudes and low self-efficacy to adhere to necessary self-care activities including diet, physical activity and self-monitoring of blood glucose. CONCLUSION: Future pharmaceutical care interventions designed to improve patients’ adherence and health outcomes in patients with type 2 diabetes should consider improving patients’ understanding of type 2 diabetes and its management, simplifying dosage regimen, improving patient's beliefs and attitudes toward type 2 diabetes, prescribed medications and different self-care activities in addition to improving patient's self efficacy to perform different treatment recommendations.
format Online
Article
Text
id pubmed-5856954
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58569542018-03-19 A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan Jarab, Anan S. Mukattash, Tareq L. Al-Azayzih, Ahmad Khdour, Maher Saudi Pharm J Article BACKGROUND: Diabetes is increasingly becoming a major health problem in Jordan and glycemic goals are often not achieved. OBJECTIVE: To explore the patients’ perspectives regarding type 2 diabetes and its management in order to “fine-tune” future pharmaceutical care intervention programs. METHOD: Focus groups method was used to explore views from individuals with type 2 diabetes attending outpatient diabetes clinic at the Royal Medical Services Hospital. All interviews were recorded, transcribed and analyzed using a thematic analysis approach. RESULTS: A total of 6 focus groups, with 6 participants in each one, were conducted. Participants in the present study demonstrated a great information needs about diabetes and the prescribed treatment. Medication regimen characteristics including rout of administration, number of prescribed medications and dosage frequency in addition to perceived side effects represented the major barriers to medication adherence. In addition to demonstrating negative beliefs about the illness and the prescribed medications, participants showed negative attitudes and low self-efficacy to adhere to necessary self-care activities including diet, physical activity and self-monitoring of blood glucose. CONCLUSION: Future pharmaceutical care interventions designed to improve patients’ adherence and health outcomes in patients with type 2 diabetes should consider improving patients’ understanding of type 2 diabetes and its management, simplifying dosage regimen, improving patient's beliefs and attitudes toward type 2 diabetes, prescribed medications and different self-care activities in addition to improving patient's self efficacy to perform different treatment recommendations. Elsevier 2018-03 2018-01-31 /pmc/articles/PMC5856954/ /pubmed/29556120 http://dx.doi.org/10.1016/j.jsps.2018.01.013 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Jarab, Anan S.
Mukattash, Tareq L.
Al-Azayzih, Ahmad
Khdour, Maher
A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title_full A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title_fullStr A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title_full_unstemmed A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title_short A focus group study of patient’s perspective and experiences of type 2 diabetes and its management in Jordan
title_sort focus group study of patient’s perspective and experiences of type 2 diabetes and its management in jordan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856954/
https://www.ncbi.nlm.nih.gov/pubmed/29556120
http://dx.doi.org/10.1016/j.jsps.2018.01.013
work_keys_str_mv AT jarabanans afocusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT mukattashtareql afocusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT alazayzihahmad afocusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT khdourmaher afocusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT jarabanans focusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT mukattashtareql focusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT alazayzihahmad focusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan
AT khdourmaher focusgroupstudyofpatientsperspectiveandexperiencesoftype2diabetesanditsmanagementinjordan